Christensen, M.M. (1996). Histochemical localization of autometallographically detectable mercury in tissues of the immune system from mice exposed to mercuric chloride. Histochem J
28, 217–225.
Christian, J.D., Lamm, T.C., Morrow, J.F. & Bostwick, D.G. (2005). Corpora amylacea in adenocarcinoma of the prostate: Incidence and histology within needle core biopsies. Mod Pathol
18, 36–39.
Cross, P.A., Bartley, C.J. & McClure, J. (1992). Amyloid in prostatic corpora amylacea. J Clin Pathol
45, 894–897.
Danscher, G. (1984). Autometallography. A new technique for light and electron microscopic visualization of metals in biological tissues (gold, silver, metal sulphides and metal selenides). Histochemistry
81, 331–335.
Danscher, G. & Møller-Madsen, B. (1985). Silver amplification of mercury sulfide and selenide: A histochemical method for light and electron microscopic localization of mercury in tissue. J Histochem Cytochem
33, 219–228.
Danscher, G. & Stoltenberg, M. (2005). Zinc-specific autometallographic in vivo selenium methods: Tracing of zinc-enriched (ZEN) terminals, ZEN pathways, and pools of zinc ions in a multitude of other ZEN cells. J Histochem Cytochem
53, 141–153.
Danscher, G., Stoltenberg, M. & Juhl, S. (1994). How to detect gold, silver and mercury in human brain and other tissues by autometallographic silver amplification. Neuropathol Appl Neurobiol
20, 454–467.
Declercq, H., Van Der Vreken, N., De Maeyer, E., Verbeeck, R., Schacht, E., De Ridder, L. & Cornelissen, M. (2004). Isolation, proliferation and differentiation of osteoblastic cells to study cell/biomaterial interactions: Comparison of different isolation techniques and source. Biomaterials
25, 757–768.
Dessombz, A., Méria, P., Bazin, D., Foy, E., Rouzière, S., Weil, R. & Daudon, M. (2011). Revisiting the chemical diversity in prostatic calculi: A SEM and FT-IR investigation. Prog Urol
21, 940–945.
Drachenberg, C.B. & Papadimitriou, J.C. (1996). Prostatic corpora amylacea and crystalloids: Similarities and differences on ultrastructural and histochemical studies. J Submicrosc Cytol Pathol
28, 141–150.
Dudley, A.C., Khan, Z.A., Shih, S.C., Kang, S.Y., Zwaans, B.M., Bischoff, J. & Klagsbrun, M. (2008). Calcification of multipotent prostate tumor endothelium. Cancer Cell
14, 201–211.
Epstein, J.I. & Eggleston, J.C. (1984). Immunohistochemical localization of prostate-specific acid phosphatase and prostate-specific antigen in stage A2 adenocarcinoma of the prostate: Prognostic implications. Hum Pathol
15, 853–859.
Epstein, J.I. & Netto, G.J. (2008). Biopsy Interpretation of the Prostate, 4th ed.
Philadelphia, PA: Lippincott Williams & Wilkins.
Eykyn, S., Bultitude, M.I., Mayo, M.E. & Lloyd-Davies, R.W. (1974). Prostatic calculi as a source of recurrent bacteriuria in the male. Br J Urol
46, 527–532.
Ford, T.F., Butcher, D.N., Masters, J.R. & Parkinson, M.C. (1985). Immunocytochemical localisation of prostate-specific antigen: Specificity and application to clinical practice. Br J Urol
57, 50–55.
Fritz, G., Botelho, H.M., Morozova-Roche, L.A. & Gomes, C.M. (2010). Natural and amyloid self-assembly of S100 proteins: Structural basis of functional diversity. FEBS J
277, 4578–4590.
Ghazizadeh, M., Kagawa, S., Maebayashi, K., Izumi, K. & Kurokawa, K. (1984). Prostatic origin of metastases: Immunoperoxidase localization of prostate-specific antigen. Urol Int
39, 9–12.
Höhn, A. & Grune, T. (2013). Lipofuscin: Formation, effects and role of macroautophagy. Redox Biol
19, 140–144.
Holmes, E.J. (1977). Crystalloids of prostatic carcinoma: Relationship to Bence-Jones crystals. Cancer
39, 2073–2080.
Hsu, T.H., Lin, S.Y., Lin, C.C. & Cheng, W.T. (2011). Preliminary feasibility study of FTIR microscopic mapping system for the rapid detection of the composited components of prostatic calculi. Urol Res
39, 165–170.
Jensen, P.E., Gardner, W.A. Jr. & Piserchia, P.V. (1980). Prostatic crystalloids: Association with adenocarcinoma. Prostate
1, 25–30.
Kato, H. & Ogawa, A. (1987). Large brushite stone in a dilated prostatic urethra. J Urol
138, 154–155.
Kiernan, J.A. (2008). Histological and Histochemical Methods: Theory and Practice, 4th ed.
Oxfordshire: Scion Publishing Ltd.
Kodaka, T., Hirayama, A., Sano, T., Debari, K., Mayahara, M. & Nakamura, M. (2008). Fine structure and mineral components of primary calculi in some human prostates. J Electron Microsc
57, 133–141.
Magura, C.E. & Spector, M. (1979). Scanning electron microscopy of human prostatic corpora amylacea and corpora calculi, and prostatic calculi. Scan Electron Microsc
3, 713–720.
Mahmoodi, M., Zhang, S., Salim, S., Hou, J.S. & Garcia, F.U. (2006). Lipofuscin pigment can be used as a prognostic marker in prostatic adenocarcinoma. Ann Diagn Pathol
10, 257–262.
Meares, E.M. (1974). Infection stones of prostate gland. Laboratory diagnosis and clinical management. Urology
4, 560–566.
Moore, R.A. (1936). Morphology of prostatic corpora amylacea and calculi. Arch Pathol
22, 24–40.
Morales, E., Polo, L.A., Pastor, L.M., Santamaría, L., Calvo, A., Zuasti, A. & Ferrer, C. (2005). Characterization of corpora amylacea glycoconjugates in normal and hyperplastic glands of human prostate. J Mol Histol
36, 235–242.
Ohtsuki, Y., Furihata, M., Inoue, K., Iwata, J., Manabe, Y., Sonobe, H., Ochi, K., Seike, H., Hashimoto, H. & Terao, N. (1992). Immunohistochemical and ultrastructural studies of intraluminal crystalloids in human prostatic carcinomas. Virchows Arch A Pathol Anat Histopathol
421, 421–425.
Pretlow, T.G., Pretlow, T.P., Yang, B., Kaetzel, C.S., Delmoro, C.M., Kamis, S.M., Bodner, D.R., Kursh, E., Resnick, M.I. & Bradley, E.L. Jr. (1991). Tissue concentrations of prostate-specific antigen in prostatic carcinoma and benign prostatic hyperplasia. Int J Cancer
49, 645–649.
Ro, J.Y., Ayala, A.G., Ordonez, N.G., Cartwright, J. Jr. & Mackay, B. (1986). Intraluminal crystalloids in prostatic adenocarcinoma. Immunohistochemical, electron microscopic, and X-ray microanalytic studies. Cancer
57, 2397–2407.
Röcken, C., Linke, R.P. & Saeger, W. (1996). Corpora amylacea in the lung, prostate and uterus. A comparative and immunohistochemical study. Pathol Res Pract
192, 998–1006.
Sfanos, K.S., Wilson, B.A., De Marzo, A.M. & Isaacs, W.B. (2009). Acute inflammatory proteins constitute the organic matrix of prostatic corpora amylacea and calculi in men with prostate cancer. Proc Natl Acad Sci U S A
106, 3443–3448.
Smith, V. (1965). Prostatic corpora amylacea and their calcification. Surg Forum
16, 501–502.
Sorensen, M.B., Stoltenberg, M., Juhl, S., Danscher, G. & Ernst, E. (1997). Ultrastructural localization of zinc ions in the rat prostate: An autometallographic study. Prostate
31, 125–130.
Stein, B.S., Vangore, S., Petersen, R.O. & Kendall, A.R. (1982). Immunoperoxidase localization of prostate-specific antigen. Am J Surg Pathol
6, 553–557.
Stein-Werblowky, R. (1978). On the etiology of cancer of the prostate. Eur Urol
4, 370–373.
Sutor, D.J. & Wooley, S.E. (1974). The crystalline composition of prostatic calculi. Br J Urol
46, 533–535.
Torres Ramirez, C., Aguilar Ruiz, J., Zuluaga Gomez, A., del Rio Samper, S. & de la Fuente Serr, A. (1981). Ultrastructure of primary or endogenous prostatic calculi. Scanning electron microscopic study. Arch Esp Urol
34, 13–22.
Vartsky, D., Shilstein, S., Bercovich, A., Huszar, M., Breskin, A., Chechik, R., Korotinsky, S., Malnick, S.D. & Moriel, E. (2003). Prostatic zinc and prostate specific antigen: An experimental evaluation of their combined diagnostic value. J Urol
170, 2258–2262.
Yanamandra, K., Alexeyev, O., Zamotin, V., Srivastava, V., Shchukarev, A., Brorsson, A.C., Tartaglia, G.G., Vogl, T., Kayed, R., Wingsle, G., Olsson, J., Dobson, C.M., Bergh, A., Elgh, F. & Morozova-Roche, L.A. (2009). Amyloid formation by the pro-inflammatory S100A8/A9 proteins in the ageing prostate. PLoS One
4, e5562.
Zarnescu, O., Craciunescu, O. & Moldovan, L. (2010). Collagen-chondroitin sulphate-hydroxyapatite porous composites: A histochemical and electron microscopy approach. Microsc Microanal
16, 137–142.
